These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25269484)

  • 1. Differential impact of selective GH deficiency and endogenous GH excess on insulin-mediated actions in muscle and liver of male mice.
    Cordoba-Chacon J; Gahete MD; McGuinness OP; Kineman RD
    Am J Physiol Endocrinol Metab; 2014 Nov; 307(10):E928-34. PubMed ID: 25269484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressor of cytokine signaling-2 deficiency induces molecular and metabolic changes that partially overlap with growth hormone-dependent effects.
    Rico-Bautista E; Greenhalgh CJ; Tollet-Egnell P; Hilton DJ; Alexander WS; Norstedt G; Flores-Morales A
    Mol Endocrinol; 2005 Mar; 19(3):781-93. PubMed ID: 15563548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated GH/IGF-I, due to somatotrope-specific loss of both IGF-I and insulin receptors, alters glucose homeostasis and insulin sensitivity in a diet-dependent manner.
    Gahete MD; Córdoba-Chacón J; Anadumaka CV; Lin Q; Brüning JC; Kahn CR; Luque RM; Kineman RD
    Endocrinology; 2011 Dec; 152(12):4825-37. PubMed ID: 21990313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term administration of pegvisomant improves hepatic insulin sensitivity and reduces soleus muscle intramyocellular lipid content in young adults with type 1 diabetes.
    Thankamony A; Tossavainen PH; Sleigh A; Acerini C; Elleri D; Dalton RN; Jackson NC; Umpleby AM; Williams RM; Dunger DB
    J Clin Endocrinol Metab; 2014 Feb; 99(2):639-47. PubMed ID: 24423298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone signaling and action in obese versus lean human subjects.
    Høgild ML; Bak AM; Pedersen SB; Rungby J; Frystyk J; Møller N; Jessen N; Jørgensen JOL
    Am J Physiol Endocrinol Metab; 2019 Feb; 316(2):E333-E344. PubMed ID: 30576246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Islet insulin content and release are increased in male mice with elevated endogenous GH and IGF-I, without evidence of systemic insulin resistance or alterations in β-cell mass.
    Cordoba-Chacon J; Majumdar N; Pokala NK; Gahete MD; Kineman RD
    Growth Horm IGF Res; 2015 Aug; 25(4):189-95. PubMed ID: 25936582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of pegvisomant treatment on substrate metabolism and insulin sensitivity in patients with acromegaly.
    Lindberg-Larsen R; Møller N; Schmitz O; Nielsen S; Andersen M; Orskov H; Jørgensen JO
    J Clin Endocrinol Metab; 2007 May; 92(5):1724-8. PubMed ID: 17341562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans.
    Hussain MA; Schmitz O; Mengel A; Glatz Y; Christiansen JS; Zapf J; Froesch ER
    J Clin Invest; 1994 Sep; 94(3):1126-33. PubMed ID: 8083353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice.
    Yakar S; Setser J; Zhao H; Stannard B; Haluzik M; Glatt V; Bouxsein ML; Kopchick JJ; LeRoith D
    J Clin Invest; 2004 Jan; 113(1):96-105. PubMed ID: 14702113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance in the liver-specific IGF-1 gene-deleted mouse is abrogated by deletion of the acid-labile subunit of the IGF-binding protein-3 complex: relative roles of growth hormone and IGF-1 in insulin resistance.
    Haluzik M; Yakar S; Gavrilova O; Setser J; Boisclair Y; LeRoith D
    Diabetes; 2003 Oct; 52(10):2483-9. PubMed ID: 14514630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy.
    Christopher M; Hew FL; Oakley M; Rantzau C; Alford F
    J Clin Endocrinol Metab; 1998 May; 83(5):1668-81. PubMed ID: 9589675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased P85alpha is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess.
    Barbour LA; Mizanoor Rahman S; Gurevich I; Leitner JW; Fischer SJ; Roper MD; Knotts TA; Vo Y; McCurdy CE; Yakar S; Leroith D; Kahn CR; Cantley LC; Friedman JE; Draznin B
    J Biol Chem; 2005 Nov; 280(45):37489-94. PubMed ID: 16166093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance.
    Kim JK; Fillmore JJ; Chen Y; Yu C; Moore IK; Pypaert M; Lutz EP; Kako Y; Velez-Carrasco W; Goldberg IJ; Breslow JL; Shulman GI
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7522-7. PubMed ID: 11390966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle mechano growth factor is preferentially induced by growth hormone in growth hormone-deficient lit/lit mice.
    Iida K; Itoh E; Kim DS; del Rincon JP; Coschigano KT; Kopchick JJ; Thorner MO
    J Physiol; 2004 Oct; 560(Pt 2):341-9. PubMed ID: 15308683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.
    Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the hepatic eukaryotic initiation factor 2alpha (eIF2alpha) endoplasmic reticulum (ER) stress response pathway on insulin-mediated ER stress and hepatic and peripheral glucose metabolism.
    Birkenfeld AL; Lee HY; Majumdar S; Jurczak MJ; Camporez JP; Jornayvaz FR; Frederick DW; Guigni B; Kahn M; Zhang D; Weismann D; Arafat AM; Pfeiffer AF; Lieske S; Oyadomari S; Ron D; Samuel VT; Shulman GI
    J Biol Chem; 2011 Oct; 286(42):36163-70. PubMed ID: 21832042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of treatment with recombinant human GH and IGF-I on visceral adipose tissue and glucose homeostasis in adults.
    Yuen KC; Dunger DB
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S55-61. PubMed ID: 16624605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic overexpression of insulin-like growth factor-II in adulthood increases basal and insulin-stimulated glucose disposal in conscious mice.
    Rossetti L; Barzilai N; Chen W; Harris T; Yang D; Rogler CE
    J Biol Chem; 1996 Jan; 271(1):203-8. PubMed ID: 8550560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term, low-dose GH therapy improves insulin sensitivity without modifying cortisol metabolism and ectopic fat accumulation in adults with GH deficiency.
    Yuen KC; Roberts CT; Frystyk J; Rooney WD; Pollaro JR; Klopfenstein BJ; Purnell JQ
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E1862-9. PubMed ID: 25013996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone-sensitive lipase knockout mice have increased hepatic insulin sensitivity and are protected from short-term diet-induced insulin resistance in skeletal muscle and heart.
    Park SY; Kim HJ; Wang S; Higashimori T; Dong J; Kim YJ; Cline G; Li H; Prentki M; Shulman GI; Mitchell GA; Kim JK
    Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E30-9. PubMed ID: 15701680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.